Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8743976 | Travel Medicine and Infectious Disease | 2017 | 7 Pages |
Abstract
The European experts differ in pre-travel anti-malarial recommendations for risk groups visiting malaria endemic areas of sub-Saharan Africa. Contraindications are not always observed and there are no uniform recommendations for high-risk groups. 9 experts would recommend atovaquone/proguanil to a traveller with severe renal impairment although most reviewed national recommendations consider this a contraindication. Discordance in recommendations, a lack of key data and few chemoprophylaxis options limit choices for pre-travel health advisors.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Mithula Shellvarajah, Christoph Hatz, Patricia Schlagenhauf,